Pharmaceutical
- Nov- 2022 -9 November
Ispen Onivyde® regimen demonstrated statistically significant improvement in overall survival, MACK stock Soar
MACK STOCK UPDATE: MACK stock soar on Ispen study – Onivyde® regimen demonstrated statistically significant improvement in overall survival in…
Read More »